νλν μΈ
νλν μΈμ νλ¨ν μΈκ³ νκ²½λ ¨μ λ° ν΄λμ€ IB νλΆμ λ§₯μ μ λλ€. **μμ ν:** κ³Όκ±°μλ μμνμμ λμ μ¦ μΉλ£μ μ¬μ©λμμΌλ, κ°μμλ λ°κ°κΈ°κ° λ§€μ° μ§§μ μ¦μ ν¬μ¬κ° νμνκ³ κ°λ μ± μνμ΄ λμ νμ¬λ κ±°μ μ¬μ©λμ§ μμΌλ©°, νλ Έλ°λ₯΄λΉνμ΄λ λ λ² ν°λΌμΈνκ³Ό κ°μ λ μμ ν μ½λ¬Όλ‘ λ체λμμ΅λλ€. > **κ²½κ³ :** κ³ μμ΄λ κ°μ κΈλ£¨μΏ λ‘ μ° ν¬ν© κ²½λ‘κ° κ²°νλμ΄ μμ΄ νλν μΈμ λν΄ λ§€μ° λμ λ μ±μ 보μ΄λ©°, μμ£Ό μ μ μ©λμμλ μ¬κ°ν μΆμ κ³Ό μ€λ μ μ λ°ν©λλ€.
μμ© κΈ°μ : Diminishes the spread of focal neural discharges by promoting sodium efflux from neurons via the **voltage-gated sodium channels** β stabilizes the neuronal membrane β raises the threshold against hyperexcitability. It also acts on Purkinje fibers in the heart to shorten the action potential duration, functioning as a Class IB antiarrhythmic.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Cats (due to severe toxicity)
- Hepatic dysfunction
- Bradycardia
- High-grade AV block
μ΄μλ°μ
- Hepatotoxicity (especially in dogs)
- Ataxia
- Sedation
- Gingival hyperplasia
- Peripheral neuropathy
- Hypotension and arrhythmias (with rapid IV administration)
μ½λ¬Ό μνΈμμ©
- Phenobarbital Β· Unpredictable effects on serum concentrations of both drugs due to CYP450 induction Β· moderate
- Chloramphenicol Β· Inhibits hepatic metabolism of phenytoin, leading to increased levels and toxicity Β· major
- Cimetidine Β· Inhibits metabolism of phenytoin, increasing risk of toxicity Β· moderate
- Corticosteroids Β· Phenytoin induces hepatic enzymes, increasing the clearance and reducing the efficacy of corticosteroids Β· moderate
λͺ¨λν°λ§
- Serum drug concentrations (therapeutic range typically 10-20 mcg/mL, though rarely monitored now due to infrequent use)
- Liver enzymes (ALT, AST, ALP) and bilirubin
- ECG and blood pressure during IV administration
κ³Όμ©λ
Clinical signs of overdose include severe ataxia, tremors, lethargy, vomiting, and paradoxical seizures. Rapid IV overdose leads to hypotension and cardiac arrest. **Treatment:** Consists of supportive care, IV fluid therapy, and cardiovascular monitoring. There is no specific antidote.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.